ATE174930T1 - Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält - Google Patents

Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält

Info

Publication number
ATE174930T1
ATE174930T1 AT92921587T AT92921587T ATE174930T1 AT E174930 T1 ATE174930 T1 AT E174930T1 AT 92921587 T AT92921587 T AT 92921587T AT 92921587 T AT92921587 T AT 92921587T AT E174930 T1 ATE174930 T1 AT E174930T1
Authority
AT
Austria
Prior art keywords
subunit
pct
transferrin receptor
human transferrin
neisseria meningitidis
Prior art date
Application number
AT92921587T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of ATE174930T1 publication Critical patent/ATE174930T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/871Neisseria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92921587T 1991-10-03 1992-09-29 Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält ATE174930T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.

Publications (1)

Publication Number Publication Date
ATE174930T1 true ATE174930T1 (de) 1999-01-15

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921587T ATE174930T1 (de) 1991-10-03 1992-09-29 Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält

Country Status (15)

Country Link
US (2) US5618540A (de)
EP (1) EP0560969B1 (de)
JP (1) JPH06503364A (de)
AT (1) ATE174930T1 (de)
AU (1) AU668522B2 (de)
CA (1) CA2096411A1 (de)
DE (1) DE69227984T2 (de)
DK (1) DK0560969T3 (de)
ES (1) ES2128358T3 (de)
FI (1) FI107262B (de)
FR (1) FR2682114B1 (de)
GR (1) GR3029580T3 (de)
HU (1) HU219762B (de)
NO (1) NO309865B1 (de)
WO (1) WO1993007172A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US5928647A (en) * 1993-01-11 1999-07-27 Dana-Farber Cancer Institute Inducing cytotoxic T lymphocyte responses
AU705998B2 (en) * 1993-11-08 1999-06-03 Connaught Laboratories Limited Haemophilus transferrin receptor genes
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
AU2107400A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) Neisseria meningitidis antigen
NZ597007A (en) 2009-05-14 2013-09-27 Sanofi Pasteur Meningococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
AU2010288240B2 (en) * 2009-08-27 2014-03-27 Novartis Ag Hybrid polypeptides including meningococcal fHBP sequences
JP2016539950A (ja) 2013-12-02 2016-12-22 ビー. シュライバーズ,アンソニー 細菌表面受容体タンパク質由来の免疫原性組成物およびワクチン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
WO1992003467A1 (en) * 1990-08-23 1992-03-05 The University Of North Carolina Of Chapel Hill Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
HU219762B (hu) 2001-07-30
DE69227984D1 (de) 1999-02-04
FI932490A0 (fi) 1993-06-01
NO932009D0 (no) 1993-06-02
FI932490A (fi) 1993-06-01
DE69227984T2 (de) 1999-05-12
FR2682114A1 (fr) 1993-04-09
FI107262B (fi) 2001-06-29
CA2096411A1 (en) 1993-04-04
AU2764092A (en) 1993-05-03
AU668522B2 (en) 1996-05-09
ES2128358T3 (es) 1999-05-16
US5928650A (en) 1999-07-27
NO309865B1 (no) 2001-04-09
US5618540A (en) 1997-04-08
FR2682114B1 (fr) 1996-02-23
GR3029580T3 (en) 1999-06-30
HU9301631D0 (en) 1993-10-28
WO1993007172A1 (fr) 1993-04-15
EP0560969B1 (de) 1998-12-23
NO932009L (no) 1993-07-20
DK0560969T3 (da) 1999-08-23
JPH06503364A (ja) 1994-04-14
EP0560969A1 (de) 1993-09-22
HUT69929A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
FR2682041B1 (fr) Vaccin contre les infections a neisseria meningitidis.
FI960102A0 (fi) Uusi farmaseuttinen seos
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
ATE174930T1 (de) Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DE69217554D1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
IL108750A (en) Pharmaceutical cognition enhancing compositions containing 1,3-dialiphatic-8-(phenylalkyl or ludanyl) xanthines as selective adenosine receptor agents
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification